Protocol Ledger

NCT05008809 · Phase III · RECRUITING

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

Interventional Phase III clinical trial protocol NCT05008809 sponsored by Dominik Paul Modest in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-12-06 Enrollment: 507 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05008809
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)507 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05008809
Protocol FieldVerified Registry Value
NCT IdentifierNCT05008809
Consolidated Lead SponsorDominik Paul Modest
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment507 participants (ESTIMATED)
Registered Start Date2021-12-06
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05008809
Hospital Research SiteLocationSite Profile
Charité Universitätsmedizin BerlinBerlin, GermanyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI